Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(−)-10,11-dihydro-10-hydroxy carbamazepine
- 31 May 2001
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 44 (2-3) , 197-206
- https://doi.org/10.1016/s0920-1211(01)00231-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide DerivativesJournal of Medicinal Chemistry, 1999
- The new generation of antiepileptic drugs: advantages and disadvantagesBritish Journal of Clinical Pharmacology, 1996
- Adverse effects of established and new antiepileptic drugs: An attempted comparisonPharmacology & Therapeutics, 1995
- Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findingsTrends in Pharmacological Sciences, 1994
- Solid phase extraction of oxcarbazepine and its metabolites from plasma for analysis by high performance liquid chromatographyBiomedical Chromatography, 1991
- Oxcarbazepine (GP 47.680): A Possible Alternative to Carbamazepine?Epilepsia, 1987
- Incidence and prevalence studies in epilepsy and their methodological problems: a review.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- The metabolism of14C-oxcarbazepine in manXenobiotica, 1986
- Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side EffectsEpilepsia, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976